Clinical Trial Update: Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma [Phase 1]

View source ↗

Summary

Phase 1 imaging study evaluating how the IL13-PE38QQR conjugate distributes in adult patients with recurrent malignant glioma before and after surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Oligodendroglioma
• Glioblastoma
• Malignant Glioma
• Oligoastrocytoma

Drugs mentioned

• Cintredekin besudotox (IL13-PE38QQR)

Snippet

Sponsor: INSYS Therapeutics Inc | Conditions: Malignant Glioma, Glioblastoma Multiforme | Phase 1 | Status: COMPLETED